Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,005
Closed -$852K 120
2021
Q3
$852K Sell
4,005
-875
-18% -$201K 0.29% 83
2021
Q2
$1.19M Hold
4,880
0.47% 56
2021
Q1
$1.21M Buy
4,880
+2,805
+135% +$669K 0.51% 57
2020
Q4
$477K Hold
2,075
0.2% 60
2020
Q3
$527K Hold
2,075
0.25% 53
2020
Q2
$489K Sell
2,075
-11,847
-85% -$2.7M 0.25% 52
2020
Q1
$2.82M Hold
13,922
1.4% 6
2019
Q4
$3.36M Sell
13,922
-1,100
-7% -$242K 1.31% 6
2019
Q3
$2.91M Sell
15,022
-200
-1% -$38.4K 1.21% 8
2019
Q2
$2.81M Buy
15,222
+700
+5% +$125K 1.17% 10
2019
Q1
$2.76M Sell
14,522
-24
-0.2% -$4.58K 0.94% 16
2018
Q4
$2.83M Buy
+14,546
New +$2.84M 1.07% 10
2015
Q4
Sell
-11,617
Closed -$1.61M 8
2015
Q3
$1.61M Hold
11,617
0.62% 45
2015
Q2
$1.78M Buy
+11,617
New +$1.86M 0.62% 47

Other funds holding AMGN

Bessemer Securities's AMGN Position: Q4 2021 in Review

Bessemer Securities sold out of Amgen (AMGN) in Q4 2021, closing a stake of 4,005 shares — an estimated $852K sold.

Bessemer Securities first reported a position in AMGN in Q2 2015 and held it in 14 quarters. The position peaked at $3.36M in Q4 2019. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • Bessemer Securities reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
  • Bessemer Securities sold 4,005 Amgen shares in Q4 2021, an estimated $852K.
  • Bessemer Securities first reported a position in Amgen in Q2 2015 and held it in 14 quarters.
  • Bessemer Securities's Amgen position peaked at $3.36M in Q4 2019.
  • 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on Bessemer Securities's 13F filing for Q4 2021, filed 31 Jan 2022.